Table of Content

1 Recombinant DNA Technology Market Introduction and Overview
1.1 Recombinant DNA Technology Definition
1.2 Research Purposes
1.3 Currency Rate
1.4 Report Timeline
1.5 Economic Analysis of Global Regions
1.6 Inflation Analysis
1.7 The Impact of the Russian-Ukrainian War on the Market
2 Market Competition by Manufacturers
2.1 Global Recombinant DNA Technology Sales and Market Share by Manufacturer
2.2 Global Recombinant DNA Technology Revenue and Market Share by Manufacturer
2.3 Global Recombinant DNA Technology Average Price by Manufacturers
2.4 Manufacturers Recombinant DNA Technology Production Sites, Area Served, Product Types
2.5 Recombinant DNA Technology Market Competitive Situation and Trends
2.5.1 Recombinant DNA Technology Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue in 2023
2.5.3 Mergers & Acquisitions, Expansion
3 Global Recombinant DNA Technology Historical Market Analysis by Type
3.1 Market Size Analysis by Types
3.1.4 Global Recombinant DNA Technology Market Share by Type 2018 VS 2022
3.2 Global Recombinant DNA Technology Revenue and Market Share by Type
3.3 Global Recombinant DNA Technology Sales and Market Share by Type
4 Global Recombinant DNA Technology Historical and Forecast Market Analysis by Application
4.1 Market Size Analysis by Application
4.1.4 Global Recombinant DNA Technology Market Share by Application 2018 VS 2022
4.2 Global Recombinant DNA Technology Revenue Market Share by Application (2018-2023)
4.3 Global Recombinant DNA Technology Sales Market Share by Application (2018-2023)
5 Global Market Growth Trends Analysis
5.1 Global Recombinant DNA Technology Market Size (2018-2023)
5.2 Recombinant DNA Technology Growth Trends Analysis by Regions
5.2.1 Recombinant DNA Technology Market Size by Regions: 2018 VS 2023 VS 2029
5.2.2 Recombinant DNA Technology Historic Revenue Market Size by Regions (2018-2023)
5.2.3 Recombinant DNA Technology Historic Sales Market Size by Regions (2018-2023)
5.3 North America
5.3.1 North America Recombinant DNA Technology Revenue by Countries (2018-2023)
5.3.2 North America Recombinant DNA Technology Sales by Countries (2018-2023)
5.3.3 North America SWOT Analysis
5.3.4 United States
5.3.5 Canada
5.4 China
5.4.1 China SWOT Analysis
5.5 Asia Pacific (Excluding China)
5.5.1 Asia Pacific Recombinant DNA Technology Revenue by Countries (2018-2023)
5.5.2 Asia Pacific Recombinant DNA Technology Sales by Countries (2018-2023)
5.5.3 Asia Pacific SWOT Analysis
5.5.4 Japan
5.5.5 Korea
5.5.6 Southeast Asia
5.5.7 India
5.5.8 Australia
5.6 EMEA
5.6.1 EMEA Recombinant DNA Technology Revenue by Countries (2018-2023)
5.6.2 EMEA Recombinant DNA Technology Sales by Countries (2018-2023)
5.6.3 EMEA SWOT Analysis
5.6.4 Europe
5.6.5 Middle East
5.6.6 Africa
5.7 Latin America
5.7.1 Latin America Recombinant DNA Technology Revenue by Countries (2018-2023)
5.7.2 Latin America Recombinant DNA Technology Sales by Countries (2018-2023)
5.7.3 Latin America SWOT Analysis
5.7.4 Brazil
5.7.5 Argentina
5.7.6 Mexico
6 Players Profiles
6.1 Monsanto Company
6.1.1 Monsanto Company Company Profile
6.1.2 Recombinant DNA Technology Product Overview
6.1.3 Monsanto Company Recombinant DNA Technology Market Performance (2018-2023)
6.1.4 Monsanto Company Business Overview
6.1.5 SWOT Analysis
6.2 Roche
6.2.1 Roche Company Profile
6.2.2 Recombinant DNA Technology Product Overview
6.2.3 Roche Recombinant DNA Technology Market Performance (2018-2023)
6.2.4 Roche Business Overview
6.2.5 SWOT Analysis
6.3 Biogen
6.3.1 Biogen Company Profile
6.3.2 Recombinant DNA Technology Product Overview
6.3.3 Biogen Recombinant DNA Technology Market Performance (2018-2023)
6.3.4 Biogen Business Overview
6.3.5 SWOT Analysis
6.4 Amgen
6.4.1 Amgen Company Profile
6.4.2 Recombinant DNA Technology Product Overview
6.4.3 Amgen Recombinant DNA Technology Market Performance (2018-2023)
6.4.4 Amgen Business Overview
6.4.5 SWOT Analysis
6.5 Novartis
6.5.1 Novartis Company Profile
6.5.2 Recombinant DNA Technology Product Overview
6.5.3 Novartis Recombinant DNA Technology Market Performance (2018-2023)
6.5.4 Novartis Business Overview
6.5.5 SWOT Analysis
6.6 Eli Lilly and Company
6.6.1 Eli Lilly and Company Company Profile
6.6.2 Recombinant DNA Technology Product Overview
6.6.3 Eli Lilly and Company Recombinant DNA Technology Market Performance (2018-2023)
6.6.4 Eli Lilly and Company Business Overview
6.6.5 SWOT Analysis
6.7 GenScript
6.7.1 GenScript Company Profile
6.7.2 Recombinant DNA Technology Product Overview
6.7.3 GenScript Recombinant DNA Technology Market Performance (2018-2023)
6.7.4 GenScript Business Overview
6.7.5 SWOT Analysis
6.8 Pfizer Inc.
6.8.1 Pfizer Inc. Company Profile
6.8.2 Recombinant DNA Technology Product Overview
6.8.3 Pfizer Inc. Recombinant DNA Technology Market Performance (2018-2023)
6.8.4 Pfizer Inc. Business Overview
6.8.5 SWOT Analysis
6.9 Novo Nordisk
6.9.1 Novo Nordisk Company Profile
6.9.2 Recombinant DNA Technology Product Overview
6.9.3 Novo Nordisk Recombinant DNA Technology Market Performance (2018-2023)
6.9.4 Novo Nordisk Business Overview
6.9.5 SWOT Analysis
6.10 Sanofi
6.10.1 Sanofi Company Profile
6.10.2 Recombinant DNA Technology Product Overview
6.10.3 Sanofi Recombinant DNA Technology Market Performance (2018-2023)
6.10.4 Sanofi Business Overview
6.10.5 SWOT Analysis
6.11 Merck KGaA
6.11.1 Merck KGaA Company Profile
6.11.2 Recombinant DNA Technology Product Overview
6.11.3 Merck KGaA Recombinant DNA Technology Market Performance (2018-2023)
6.11.4 Merck KGaA Business Overview
6.11.5 SWOT Analysis
6.12 Profacgen
6.12.1 Profacgen Company Profile
6.12.2 Recombinant DNA Technology Product Overview
6.12.3 Profacgen Recombinant DNA Technology Market Performance (2018-2023)
6.12.4 Profacgen Business Overview
6.12.5 SWOT Analysis
6.13 Biocon
6.13.1 Biocon Company Profile
6.13.2 Recombinant DNA Technology Product Overview
6.13.3 Biocon Recombinant DNA Technology Market Performance (2018-2023)
6.13.4 Biocon Business Overview
6.13.5 SWOT Analysis
6.14 GlaxoSmithKline
6.14.1 GlaxoSmithKline Company Profile
6.14.2 Recombinant DNA Technology Product Overview
6.14.3 GlaxoSmithKline Recombinant DNA Technology Market Performance (2018-2023)
6.14.4 GlaxoSmithKline Business Overview
6.14.5 SWOT Analysis
6.15 Cibus
6.15.1 Cibus Company Profile
6.15.2 Recombinant DNA Technology Product Overview
6.15.3 Cibus Recombinant DNA Technology Market Performance (2018-2023)
6.15.4 Cibus Business Overview
6.15.5 SWOT Analysis
6.16 Horizon Discovery Group
6.16.1 Horizon Discovery Group Company Profile
6.16.2 Recombinant DNA Technology Product Overview
6.16.3 Horizon Discovery Group Recombinant DNA Technology Market Performance (2018-2023)
6.16.4 Horizon Discovery Group Business Overview
6.16.5 SWOT Analysis
6.17 New England Biolabs
6.17.1 New England Biolabs Company Profile
6.17.2 Recombinant DNA Technology Product Overview
6.17.3 New England Biolabs Recombinant DNA Technology Market Performance (2018-2023)
6.17.4 New England Biolabs Business Overview
6.17.5 SWOT Analysis
7 Recombinant DNA Technology Manufacturing Cost Analysis
7.1 Recombinant DNA Technology Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Recombinant DNA Technology
7.4 Recombinant DNA Technology Industrial Chain Analysis
8 Market Channel, Distributors, Traders and Dealers
8.1 Market Channel Status
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.2 Recombinant DNA Technology Typical Distributors
8.3 Recombinant DNA Technology Typical Customers
9 Recombinant DNA Technology Industry Dynamic Analysis
9.1 Recombinant DNA Technology Market Trends Analysis
9.2 Recombinant DNA Technology Market Drivers Analysis
9.3 Recombinant DNA Technology Market Challenges Analysis
9.4 Recombinant DNA Technology Market Restraints Analysis
10 Global Recombinant DNA Technology Forecast Market Analysis by Type & Application
10.1 Global Recombinant DNA Technology Revenue Market Forecast by Type (2023-2029)
10.2 Global Recombinant DNA Technology Sales Market Forecast by Type (2023-2029)
10.3 Recombinant DNA Technology Revenue Market Forecast by Application (2023-2029)
10.4 Recombinant DNA Technology Sales Market Forecast by Application (2023-2029)
11 Global Recombinant DNA Technology Forecast Market Analysis by Region
11.1 Recombinant DNA Technology Revenue Market Forecast by Region (2023-2029)
11.2 Recombinant DNA Technology Sales Market Forecast by Region (2023-2029)
11.3 North America Recombinant DNA Technology Forecast Market Analysis
11.4 EMEA Recombinant DNA Technology Forecast Market Analysis
11.5 China Recombinant DNA Technology Forecast Market Analysis
11.6 Asia-Pacific Recombinant DNA Technology Forecast Market Analysis
11.7 Latin America Recombinant DNA Technology Forecast Market Analysis
12 Research Findings and Conclusion